Nuclear medicine and information systems vendor ADAC Laboratoriesreported sharply higher sales and net income for its second quarter(end-March). The Milpitas, CA, company posted revenues of $58.4million, a company record, compared with revenues of $44.7
Nuclear medicine and information systems vendor ADAC Laboratoriesreported sharply higher sales and net income for its second quarter(end-March). The Milpitas, CA, company posted revenues of $58.4million, a company record, compared with revenues of $44.7 millionin the second quarter of 1995. Net income rose to $3.9 million,compared with $2.8 million in the corresponding period a yearago.
Bookings also increased, jumping 36% to $61 million and addingto the company's backlog. Nuclear medicine product bookings were$40 million for the quarter, a strong increase over the $31 millionin the same period last year but lower than the $48 million inthe first quarter of 1996. ADAC chairman and CEO David Lowe saidthat the drop was most likely due to a seasonal softening of theU.S. nuclear medicine market, as well as a reduction in servicecontract renewals commonly experienced in the second quarter.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.